trending Market Intelligence /marketintelligence/en/news-insights/trending/Ejc0m-_aFGcIjdM9-56P_Q2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Siemens Healthineers to buy robotics maker Corindus Vascular for $1.1B

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Siemens Healthineers to buy robotics maker Corindus Vascular for $1.1B

Germany-based Siemens Healthineers AG is acquiring Corindus Vascular Robotics Inc. for $1.1 billion.

Siemens Healthineers' Siemens Medical Solutions unit will acquire all the issued and outstanding common shares of Corindus for $4.28 per share in cash. Shares in the Waltham, Mass.-based robotics company closed at $2.42 on Aug. 7, the last day before the deal was announced.

The deal will combine Siemens Healthineers' imaging, digital and artificial intelligence tools with Corindus' precision robotics platform for treating patients with cardiovascular or peripheral disease.

The boards of Siemens Healthineers and Corindus Vascular have both approved the transaction.

Completion of the deal is expected to occur in the fourth quarter, subject to the approval of Corindus shareholders, antitrust clearance and other customary closing conditions.

Citigroup Global Markets Inc. is acting as exclusive financial adviser to Corindus, while Cadwalader Wickersham & Taft LLP is serving as its legal adviser.